🔴 Capricor Therapeutics is trading 5.58% down; no confirmed company-specific explanation

Capricor Therapeutics is trading 5.58% lower at $6.25, with no confirmed company-specific announcement explaining the decline.

• The decline followed a 6.42% gain on October 29.
• October 30 search results identified no confirmed company-specific announcement; the investor news page lists an October 5 update, not a new October 30 release.
• Broader U.S. markets were under pressure, but reports focused on technology and did not establish a link to the stock’s decline. No volume data was provided, so activity cannot be assessed.